Dr Lisa Devine discusses recently updated advice regarding the risk of drug-induced liver injury with fezolinetant and new recommendations on monitoring of liver function before and during treatment.
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.